Arlington Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.41M Buy
95,329
+14,532
+18% +$673K 1.63% 35
2025
Q1
$4.93M Hold
80,797
1.93% 6
2024
Q4
$4.57M Sell
80,797
-10,000
-11% -$566K 1.77% 6
2024
Q3
$4.7M Buy
90,797
+12,491
+16% +$646K 1.84% 5
2024
Q2
$3.25M Buy
78,306
+15,773
+25% +$655K 1.61% 26
2024
Q1
$3.39M Buy
62,533
+60,558
+3,066% +$3.28M 1.73% 13
2023
Q4
$101K Buy
+1,975
New +$101K 0.03% 102
2023
Q3
Sell
-1,692
Closed -$108K 384
2023
Q2
$108K Sell
1,692
-182
-10% -$11.6K 0.02% 236
2023
Q1
$130K Sell
1,874
-317
-14% -$22K 0.02% 170
2022
Q4
$158K Buy
2,191
+404
+23% +$29.1K 0.03% 109
2022
Q3
$127K Sell
1,787
-172
-9% -$12.2K 0.05% 116
2022
Q2
$151K Buy
1,959
+643
+49% +$49.6K 0.05% 119
2022
Q1
$96K Buy
1,316
+74
+6% +$5.4K 0.03% 183
2021
Q4
$77K Sell
1,242
-1,019
-45% -$63.2K 0.02% 230
2021
Q3
$134K Buy
2,261
+1,579
+232% +$93.6K 0.04% 146
2021
Q2
$46K Hold
682
0.02% 201
2021
Q1
$43K Hold
682
0.02% 257
2020
Q4
$42K Hold
682
0.02% 113
2020
Q3
$41K Hold
682
0.02% 107
2020
Q2
$40K Buy
682
+593
+666% +$34.8K 0.02% 110
2020
Q1
$5K Sell
89
-400
-82% -$22.5K ﹤0.01% 182
2019
Q4
$31K Buy
489
+89
+22% +$5.64K 0.02% 151
2019
Q3
$20K Hold
400
0.01% 139
2019
Q2
$18K Sell
400
-1,169
-75% -$52.6K 0.01% 181
2019
Q1
$75K Buy
1,569
+169
+12% +$8.08K 0.05% 106
2018
Q4
$73K Buy
1,400
+400
+40% +$20.9K 0.05% 102
2018
Q3
$62K Buy
+1,000
New +$62K 0.04% 118